- Home
- WWW vs RCUS Comparison
WWW vs RCUS Comparison
Compare WWW & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWW
- RCUS
- Stock Information
- Founded
- WWW 1883
- RCUS 2015
- Country
- WWW United States
- RCUS United States
- Employees
- WWW N/A
- RCUS N/A
- Industry
- WWW Shoe Manufacturing
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- WWW Consumer Discretionary
- RCUS Health Care
- Exchange
- WWW Nasdaq
- RCUS Nasdaq
- Market Cap
- WWW 1.0B
- RCUS 906.4M
- IPO Year
- WWW N/A
- RCUS 2018
- Fundamental
- Price
- WWW $19.94
- RCUS $8.47
- Analyst Decision
- WWW Strong Buy
- RCUS Buy
- Analyst Count
- WWW 7
- RCUS 10
- Target Price
- WWW $18.86
- RCUS $23.75
- AVG Volume (30 Days)
- WWW 1.4M
- RCUS 1.1M
- Earning Date
- WWW 08-06-2025
- RCUS 08-07-2025
- Dividend Yield
- WWW 2.01%
- RCUS N/A
- EPS Growth
- WWW N/A
- RCUS N/A
- EPS
- WWW 0.90
- RCUS N/A
- Revenue
- WWW $1,772,400,000.00
- RCUS $141,000,000.00
- Revenue This Year
- WWW $4.96
- RCUS N/A
- Revenue Next Year
- WWW $5.48
- RCUS $28.73
- P/E Ratio
- WWW $22.25
- RCUS N/A
- Revenue Growth
- WWW N/A
- RCUS N/A
- 52 Week Low
- WWW $9.58
- RCUS $6.50
- 52 Week High
- WWW $24.64
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- WWW 68.68
- RCUS 45.47
- Support Level
- WWW $17.90
- RCUS $7.92
- Resistance Level
- WWW $20.26
- RCUS $8.81
- Average True Range (ATR)
- WWW 0.73
- RCUS 0.45
- MACD
- WWW 0.14
- RCUS -0.06
- Stochastic Oscillator
- WWW 91.30
- RCUS 39.02
About WWW Wolverine World Wide Inc.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.